Cinnamic acid-13C3
Cinnamic acid-13C3 (3-Phenylacrylic acid-13C3) is the 13C labeled Cinnamic acid. Cinnamic acid has potential use in cancer intervention, with IC50s of 1-4.5 mM in glioblastoma, melanoma, prostate and lung carcinoma cells[1][2].
Product Specifications
CAS Number
2734410-01-4
Product Name Alternative
3-Phenylacrylic acid-13C3; β-Phenylacrylic acid-13C3
UNSPSC
12352005
Target
Endogenous Metabolite; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Metabolic Enzyme/Protease; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cinnamic-acid-13c3.html
Purity
99.91
Solubility
DMSO : 125 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O[13C](/[13CH]=[13CH]/C1=CC=CC=C1)=O
Molecular Formula
C6 13C3H8O2
Molecular Weight
151.14
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Liu L, et al. Cinnamic acid: a natural product with potential use in cancer intervention. Int J Cancer. 1995 Jul 28;62 (3) :345-50.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15170967 1 Vial
Lentiviral mouse Mucl2 shRNA (UAS) - Lentiviral mouse Mucl2 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
MBS6318897-01 0.1 mL
Mapkapk3, NT (Mapkapk3, MAP kinase-activated protein kinase 3) (MaxLight 490)
Sign In for Pricing
View Details MBS6318897-02 5x 0.1 mL
Mapkapk3, NT (Mapkapk3, MAP kinase-activated protein kinase 3) (MaxLight 490)
Sign In for Pricing
View Details